Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion type Assertion NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_head.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion evidence source_evidence_literature NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion SIO_000772 14585257 NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion wasDerivedFrom befree-20150227 NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion wasGeneratedBy ECO_0000203 NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.